Security file · CUSIP 10806XAD4
BRIDGEBIO PHARMA INC
BRIDGEBIO PHARMA INC · held by 1 tracked manager in Q4 2025.
Tracked holders · Q4 2025
1
+0 vs Q3 2025
Aggregate reported value
$2.87M
sum of holders' reported positions
New holders this quarter
0
0 added · 1 trimmed
Holder return since filing
—
weighted by each holder's position share · since filing
Ownership · Q4 2025
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Howard Marks - Oaktree Capital Managementfiled 17 Feb ET | 0.04% | 2.55M | -76.3% | — | — | $2.87M | Trimmed |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q4 2025 | 1 | +0 | $2.87M | 2.55M |
| Q3 2025 | 1 | +0 | $10.63M | 10.76M |
| Q2 2025 | 1 | +0 | $16.90M | 18.06M |
| Q4 2024 | 1 | +0 | $3.26M | 3.80M |
| Q3 2024 | 1 | +0 | $2.00M | 2.38M |
| Q2 2024 | 1 | +0 | $3.04M | 3.82M |
| Q4 2023 | 1 | +0 | $4.28M | 5.03M |
| Q3 2023 | 1 | +0 | $4.86M | 6.49M |
| Q1 2023 | 1 | — | $2.58M | 3.98M |